showed in a study of patients with unresectable metastatic colorectal cancer that the lymphocyte-c-reactive protein ratio was the most sensitive predictor of sustained survival among all prognostic scores based on inflammation. This evidence concerns the gene CRP and metastatic colorectal cancer.